As described previously, exogenous expression of TGFβ RII in CBS colon cancer cells (CBS-RII) enhanced TGFβ signaling, resulting in reduced proliferation, increased apoptosis and suppressed metastatic potential in an orthotopic model in vivo [4]. The gene discussed is TGFB1; the disease is colonic neoplasm.